Anti-CKM polyclonal antibody

Can the cosmological dynamics responsible for settling down the present values of the Cabibbo-Kobayashi-Maskawa matrix be related to electroweak symmetry breaking? If the Standard Model Yukawa couplings varied in the early universe and started with order one values before electroweak symmetry breaking, the CP violation associated with the CKM matrix could be the origin of the matter-antimatter asymmetry. The large effective Yukawa couplings which lead to the enhanced CP violation can also help in achieving a strong first-order electroweak phase transition. We study in detail the feasibility of this idea by implementing dynamical Yukawa couplings in the context of the Froggatt-Nielsen mechanism. We discuss two main realizations of such a mechanism, related phenomenology, cosmological and collider bounds, and provide an estimate of the baryonic yield. A generic prediction is that this scenario always features a new scalar field below the electroweak scale. We point out ways to get around this conclusion.

Background There is little information about quality of life (QoL) for patients with end-stage kidney disease (ESKD) choosing conservative kidney management (CKM). The Frail and Elderly Patients on Dialysis (FEPOD) study demonstrated that frailty was associated with poorer QoL outcomes with little difference between dialysis modalities [assisted peritoneal dialysis (aPD) or haemodialysis (HD)]. We therefore extended the FEPOD study to include CKM patients with estimated glomerular filtration rate 10mL/min/1.73m(2) (i.e. individuals with ESKD otherwise likely to be managed with dialysis). Methods CKM patients were propensity matched to HD and aPD patients by age, gender, ethnicity, diabetes status and index of deprivation. QoL outcomes measured were Short Form-12 (SF12), Hospital Anxiety and Depression Scale depression score, symptom score, Illness Intrusiveness Rating Scale (IIRS) and Renal Treatment Satisfaction Questionnaire. Frailty was assessed using the Clinical Frailty Scale. Generalized linear modelling was used to assess the impact of treatment modality on QoL outcomes, adjusting for baseline characteristics. Results In total, 84 (28 CKM, 28 HD and 28 PD) patients were included. Median age for the cohort was 82 (79-88)years. Compared with CKM, aPD was associated with higher SF12 physical component score (PCS) [Exp B (95% confidence interval)=1.20 (1.00-1.45), P<0.05] and lower symptom score [Exp B=0.62 (0.43-0.90), P=0.01]; depression score was lower in HD compared with CKM [Exp B=0.70 (0.52-0.92), P=0.01]. Worsening frailty was associated with higher depression scores [Exp B=2.59 (1.45-4.62), P<0.01], IIRS [Exp B=1.20 (1.12-1.28), P<0.01] and lower SF12 PCS [Exp B=0.87 (0.83-0.93), P<0.01]. Conclusion Treatment by dialysis, both with aPD and HD, improved some QoL measures. Overall, aPD was equal to or slightly better than the other modalities in this elderly population. However, as in the primary FEPOD study, frailty was associated with worse QoL measures irrespective of CKD modality. These findings highlight the need for an individualized approach to the management of ESKD in older people.